Financhill
Buy
54

BOLT Quote, Financials, Valuation and Earnings

Last price:
$5.88
Seasonality move :
-11.17%
Day range:
$5.82 - $6.07
52-week range:
$4.41 - $12.40
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
12.58x
P/B ratio:
0.35x
Volume:
12.4K
Avg. volume:
46.7K
1-year change:
-49.09%
Market cap:
$11.4M
Revenue:
$7.7M
EPS (TTM):
-$16.80
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $231K $1.3M $5.7M $7.9M $7.7M
Revenue Growth (YoY) 7.44% 445.46% 354.68% 37.48% -2.36%
 
Cost of Revenues -- $3.7M $4.9M $1.9M $2.2M
Gross Profit -- -$2.4M $838K $6M $5.5M
Gross Profit Margin -- -191.43% 14.63% 76.08% 71.64%
 
R&D Expenses $37.9M $72M $68.2M $59.7M $55.3M
Selling, General & Admin $9.1M $18.4M $22.9M $22.5M $18.5M
Other Inc / (Exp) -$11.7M -$6.1M -- -- -$137K
Operating Expenses $49.2M $90.4M $91.2M $82.2M $73.7M
Operating Income -$49.2M -$92.8M -$90.3M -$76.2M -$68.2M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$60.7M -$98.6M -$88.1M -$69.2M -$63.1M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -$60.7M -$98.6M -$88.1M -$69.2M -$63.1M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$60.7M -$98.6M -$88.1M -$69.2M -$63.1M
 
Basic EPS (Cont. Ops) -$1.68 -$2.64 -$2.36 -$1.83 -$33.06
Diluted EPS (Cont. Ops) -$1.68 -$2.64 -$2.36 -$1.83 -$33.06
Weighted Average Basic Share $36.2M $37.4M $37.4M $37.8M $1.9M
Weighted Average Diluted Share $36.2M $37.4M $37.4M $37.8M $1.9M
 
EBITDA -$46.7M -$89.1M -$85.4M -$74.3M -$66.1M
EBIT -$49.2M -$92.8M -$90.3M -$76.2M -$68.2M
 
Revenue (Reported) $231K $1.3M $5.7M $7.9M $7.7M
Operating Income (Reported) -$49.2M -$92.8M -$90.3M -$76.2M -$68.2M
Operating Income (Adjusted) -$49.2M -$92.8M -$90.3M -$76.2M -$68.2M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue $752K $2.1M $2.5M $1.1M $2.2M
Revenue Growth (YoY) -- 180.85% 19.7% -54.87% 90.1%
 
Cost of Revenues -- $1.1M $462K $440K $290K
Gross Profit -- $991K $2.1M $701K $1.9M
Gross Profit Margin -- 46.92% 81.73% 61.44% 86.63%
 
R&D Expenses $18.3M $17.9M $14.5M $13.3M $6.2M
Selling, General & Admin $4.9M $5.5M $5.8M $3.8M $3.3M
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $23.5M $23.3M $20.2M $17.1M $9.6M
Operating Income -$23.5M -$22.3M -$18.2M -$16.4M -$7.7M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$23.4M -$21.8M -$16.3M -$15.2M -$7.1M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -$23.4M -$21.8M -$16.3M -$15.2M -$7.1M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$23.4M -$21.8M -$16.3M -$15.2M -$7.1M
 
Basic EPS (Cont. Ops) -$0.63 -$0.58 -$0.43 -$0.40 -$3.72
Diluted EPS (Cont. Ops) -$0.63 -$0.58 -$0.43 -$0.40 -$3.72
Weighted Average Basic Share $37.2M $37.5M $37.9M $38.3M $1.9M
Weighted Average Diluted Share $37.2M $37.5M $37.9M $38.3M $1.9M
 
EBITDA -$22.5M -$21.2M -$17.7M -$16M -$7.4M
EBIT -$23.5M -$22.3M -$18.2M -$16.4M -$7.7M
 
Revenue (Reported) $752K $2.1M $2.5M $1.1M $2.2M
Operating Income (Reported) -$23.5M -$22.3M -$18.2M -$16.4M -$7.7M
Operating Income (Adjusted) -$23.5M -$22.3M -$18.2M -$16.4M -$7.7M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue $752K $4.8M $7.2M $9.8M $5.2M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- $4M $1.9M $1.5M
Gross Profit -$2.5M -$121K $3.2M $7.9M $3.7M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $64.5M $74.1M $58.1M $60.2M $33.8M
Selling, General & Admin $15.4M $22.4M $22.6M $20M $14.6M
Other Inc / (Exp) -$20.2M -- -- $1.1M --
Operating Expenses $80.2M $96.2M $80.7M $80.3M $48.4M
Operating Income -$82.6M -$96.4M -$77.5M -$72.3M -$44.7M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$102.5M -$95.3M -$71.3M -$65.1M -$42.7M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -$102.5M -$95.3M -$71.3M -$65.1M -$42.7M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$102.5M -$95.3M -$71.3M -$65.1M -$42.7M
 
Basic EPS (Cont. Ops) -$3.26 -$2.55 -$1.89 -$1.71 -$16.80
Diluted EPS (Cont. Ops) -$3.26 -$2.55 -$1.89 -$1.71 -$16.80
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA -$79.1M -$91.7M -$73.5M -$70.5M -$43.2M
EBIT -$82.6M -$96.4M -$77.5M -$72.3M -$44.7M
 
Revenue (Reported) $752K $4.8M $7.2M $9.8M $5.2M
Operating Income (Reported) -$82.6M -$96.4M -$77.5M -$72.3M -$44.7M
Operating Income (Adjusted) -$82.6M -$96.4M -$77.5M -$72.3M -$44.7M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue $752K $4.3M $5.8M $7.7M $5.2M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $1.7M $2.6M $2.8M $1.4M $1M
Gross Profit -$1.7M $276K $3M $6.3M $4.2M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $50.4M $52.6M $42.4M $44.4M $22.5M
Selling, General & Admin $13.3M $17.3M $17M $14.5M $10.7M
Other Inc / (Exp) -$6.1M -- -- $1.1M $22K
Operating Expenses $64M $69.6M $59.4M $58.9M $33.2M
Operating Income -$65.7M -$69.3M -$56.4M -$52.6M -$29M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$71.4M -$68.1M -$51.3M -$47.2M -$26.7M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -$71.4M -$68.1M -$51.3M -$47.2M -$26.7M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$71.4M -$68.1M -$51.3M -$47.2M -$26.7M
 
Basic EPS (Cont. Ops) -$2.40 -$1.83 -$1.36 -$1.24 -$8.47
Diluted EPS (Cont. Ops) -$2.40 -$1.83 -$1.36 -$1.24 -$8.47
Weighted Average Basic Share $95.9M $111.9M $113.3M $114.4M $42.2M
Weighted Average Diluted Share $95.9M $111.9M $113.3M $114.4M $42.2M
 
EBITDA -$62.9M -$65.6M -$53.6M -$51.2M -$28M
EBIT -$65.7M -$69.3M -$56.4M -$52.6M -$29M
 
Revenue (Reported) $752K $4.3M $5.8M $7.7M $5.2M
Operating Income (Reported) -$65.7M -$69.3M -$56.4M -$52.6M -$29M
Operating Income (Adjusted) -$65.7M -$69.3M -$56.4M -$52.6M -$29M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $22.8M $186.2M $168.9M $102.2M $48.1M
Short Term Investments $17.3M $158.8M $159.6M $91.4M $40.1M
Accounts Receivable, Net -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- $906K $1M
Other Current Assets $2.5M $2.9M $3.9M $1.1M $509K
Total Current Assets $25.4M $189.2M $172.7M $105.5M $50.8M
 
Property Plant And Equipment $16.4M $30.6M $28.5M $24.1M $24.9M
Long-Term Investments $1.6M $86.9M $25.5M $28.2M $23.9M
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $2.5M $2.6M $2.6M $3.6M $1M
Total Assets $46.5M $307.7M $227.8M $159.8M $99.6M
 
Accounts Payable $1.6M $3.6M $3.6M $3M $1.5M
Accrued Expenses $3.8M $7.5M $10.3M $6.7M $4.9M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $1.5M $2.5M $2.4M $2.8M $2.3M
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $11.3M $21.3M $23.1M $20.5M $15.9M
 
Long-Term Debt $34.6M $21.9M $20.2M $17.4M $23M
Capital Leases -- -- -- -- --
Total Liabilities $46.2M $57.6M $56.3M $47M $42.4M
 
Common Stock -- -- -- $1K --
Other Common Equity Adj -- -$321K -$919K $37K $97K
Common Equity -$104.9M $250.1M $171.5M $112.7M $57.2M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $349K $250.1M $171.5M $112.7M $57.2M
 
Total Liabilities and Equity $46.5M $307.7M $227.8M $159.8M $99.6M
Cash and Short Terms $22.8M $186.2M $168.9M $102.2M $48.1M
Total Debt $34.6M $21.9M $20.2M $17.4M $23M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Cash and Equivalents $212.9M $171.1M $119.7M $54.6M $32.7M
Short Term Investments $189.2M $160.5M $110.6M $44.4M --
Accounts Receivable, Net -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets $9.6M $3.7M $5.7M $2.6M --
Total Current Assets $222.5M $174.8M $125.5M $57.1M $35.6M
 
Property Plant And Equipment $30.9M $29.7M $25.1M $20.3M $21.4M
Long-Term Investments $79.2M $40M $23.4M $31.6M $7.9M
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $2.6M $2.6M $3.1M $1.3M --
Total Assets $333.6M $245.5M $175.4M $109.3M $65.1M
 
Accounts Payable $5.2M $3.8M $3.7M $1.5M $1.5M
Accrued Expenses $7M $10.7M $5.6M $8.6M --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $2.4M $2.4M $2.7M $2.8M --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $23.7M $24.2M $18.8M $18.1M $10M
 
Long-Term Debt $22.5M $20.9M $18.2M $15.4M $20.9M
Capital Leases -- -- -- -- --
Total Liabilities $58.6M $57.1M $47.1M $37.3M $33M
 
Common Stock -- -- $1K $1K --
Other Common Equity Adj -- -- -$174K $205K --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $274.9M $188.4M $128.3M $72M $32.1M
 
Total Liabilities and Equity $333.6M $245.5M $175.4M $109.3M $65.1M
Cash and Short Terms $212.9M $171.1M $119.7M $54.6M $32.7M
Total Debt $22.5M $20.9M $18.2M $15.4M $20.9M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders -$60.7M -$98.6M -$88.1M -$69.2M -$63.1M
Depreciation & Amoritzation $2.5M $3.7M $4.9M $1.9M $1.8M
Stock-Based Compensation $1.4M $8.5M $9.6M $9.2M $7.4M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -$47.3M -$57.1M -$76.5M -$69.5M -$61.3M
 
Capital Expenditures $3.3M $2.3M $2M $206K $41K
Cash Acquisitions -- -- -- -- --
Cash From Investing -$20.6M -$232.2M $57.9M $71M $57.6M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$2M -- -- -- --
Cash From Financing $39.6M $311.1M $503K $253K $108K
 
Beginning Cash (CF) $5.5M $27.4M $9.2M $10.8M $8M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$28.3M $21.8M -$18.1M $1.8M -$3.6M
Ending Cash (CF) -$22.8M $49.2M -$8.9M $12.6M $4.4M
 
Levered Free Cash Flow -$50.6M -$59.4M -$78.5M -$69.7M -$61.3M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Net Income to Stockholders -$23.4M -$21.8M -$16.3M -$15.2M -$7.1M
Depreciation & Amoritzation $1.1M $1.1M -$988K $440K $290K
Stock-Based Compensation $2.2M $2.1M $2.3M $1.1M $407K
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -$18.7M -$13.5M -$16.7M -$14M -$9.7M
 
Capital Expenditures $1M $735K $165K $41K $72K
Cash Acquisitions -- -- -- -- --
Cash From Investing -$16.1M $1.5M $12.7M $17.1M $17.9M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing $185K -- -- -- --
 
Beginning Cash (CF) $23.6M $10.6M $9.2M $10.2M $18.5M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$34.7M -$12M -$4.1M $3.2M $8.2M
Ending Cash (CF) -$11M -$1.4M $5.1M $13.3M $26.7M
 
Levered Free Cash Flow -$19.7M -$14.2M -$16.9M -$14M -$9.8M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Net Income to Stockholders -$102.5M -$95.3M -$71.3M -$65.1M -$42.7M
Depreciation & Amoritzation $3.5M $4.6M $2.6M $1.8M $1.5M
Stock-Based Compensation $6.9M $9.6M $9.3M $8.3M $2.9M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -$52.2M -$76.3M -$73.2M -$61.1M -$47.1M
 
Capital Expenditures $2.7M $2.3M $384K $47K $72K
Cash Acquisitions -- -- -- -- --
Cash From Investing -$251.5M $62.5M $71.7M $61.2M $55.5M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing $309.5M $854K $291K $185K $43K
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $5.9M -$13M -$1.3M $214K $8.4M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$54.8M -$78.7M -$73.6M -$61.2M -$47.2M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Net Income to Stockholders -$71.4M -$68.1M -$51.3M -$47.2M -$26.7M
Depreciation & Amoritzation $2.8M $3.7M $1.4M $1.4M $1M
Stock-Based Compensation $6.4M $7.5M $7.2M $6.2M $1.7M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -$39.3M -$58.6M -$55.3M -$46.9M -$32.7M
 
Capital Expenditures $1.8M $1.8M $200K $41K $72K
Cash Acquisitions -- -- -- -- --
Cash From Investing -$253.2M $41.4M $55.2M $45.3M $43.2M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing $310.6M $359K $147K $79K $14K
 
Beginning Cash (CF) $177.4M $77.3M $37.4M $20.6M $38.1M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $18.1M -$16.8M $116K -$1.4M $10.5M
Ending Cash (CF) $195.5M $60.5M $37.6M $19.2M $48.6M
 
Levered Free Cash Flow -$41M -$60.3M -$55.5M -$46.9M -$32.8M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Stan Druckenmiller Sell Broadcom Stock?
Why Did Stan Druckenmiller Sell Broadcom Stock?

In Q3, legendary macro investor Stan Druckenmiller sold his entire…

Why Is CoreWeave Stock Down So Much?
Why Is CoreWeave Stock Down So Much?

AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…

Why Did Stan Druckenmiller Buy MercadoLibre Stock?
Why Did Stan Druckenmiller Buy MercadoLibre Stock?

In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
65
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Buy
51
Is GOOGL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Buy
70
RGC alert for Jan 8

Regencell Bioscience Holdings Ltd. [RGC] is down 21.5% over the past day.

Buy
64
RVMD alert for Jan 8

Revolution Medicines, Inc. [RVMD] is up 4.61% over the past day.

Sell
38
CRNX alert for Jan 8

Crinetics Pharmaceuticals, Inc. [CRNX] is down 0.23% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock